Expertise in
2
conditions

Janja Ocvirk

Ljubljana, SI 
Expertise in
2
conditions
Ljubljana, SI 

Overview

Janja Ocvirk practices practicing medicine in Ljubljana, Slovenia.

Ocvirk is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Colorectal Cancer, Melanoma, Peripheral T-Cell Lymphoma, Renal Cell Carcinoma (RCC), and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 2 clinical trials.

Locations

Ljubljana, Slovenia
Other Locations
Izola, Slovenia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Induction Versus Consolidation Chemotherapy in Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer With High Risk of Recurrence (ICONA Study)
Induction Versus Consolidation Chemotherapy in Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer With High Risk of Recurrence (ICONA Study)
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2026
Intervention Type: Drug
Study Phase: Phase 2
Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II
Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II
Enrollment Status: Completed
Publish Date: March 24, 2021
Intervention Type: Procedure, Drug, Device
Study Phase: Phase 2
View 1 Less Clinical Trial

38 Total Publications

Correction: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Correction: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Journal: BJC reports
Published: April 02, 2026

Frequently Asked Questions about Janja Ocvirk

Is Janja Ocvirk a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Janja Ocvirk is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Janja Ocvirk participate in research or clinical trials?

Yes. Janja Ocvirk has published 38 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Janja Ocvirk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ocvirk's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile